News
Among children and adolescents with episodic migraine, fremanezumab significantly reduced monthly migraine days.
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The latest Global Antimicrobial Resistance and Use Surveillance System report highlights disparities in access to and use of ...
Now, 50 years after that war’s end, the Wall continues to draw more than five million visitors every year. To take it all in, you would have to stand in the middle of the memorial at the wall ...
In the trials, 1,531 patients in EAGLE-2 and 1,605 patients in EAGLE-3 were randomly assigned in a 1:1 ratio to receive either Blujepa at a dose of 1,500 mg twice daily ... non-inferior to ...
Patients were enrolled at 1 of 219 centers worldwide and randomly assigned to receive either oral gepotidacin (1500 mg twice daily for 5 days) or oral nitrofurantoin ... in 50.6% (n = 162 ...
or 100 mg nitrofurantoin twice daily (n = 287) for 5 days. Therapeutic success (composite of clinical success plus microbiological success) was achieved in 50.6% of patients in the gepotidacin arm vs ...
He recovered uneventfully and was discharged on February 17 after being placed on nitrofurantoin, 50 mg. 3 times a day, prophylactically. Nine days later, he noted the onset of fever and myalgia.
Two years later David 13 reported his findings in a seven-year-old girl who had received nitrofurantoin, 25 or 50 mg twice a day, over a period of three and a half years. During the last year the ...
Adult- PO- The recommended dose is 50-100 mg 4 times/day for 7 days. Dual-release preparation: 100 mg twice daily.
EAGLE-2 and EAGLE-3 compared the efficacy and safety of gepotidacin (1,500 mg administered orally ... demonstrated therapeutic success in 50.6% of participants compared to 47% of participants ...
Poloxamer 188, polyethylene glycol 6000, and gelucire 50/13 were purchased from Sigma-Aldrich (Mumbai, Maharashtra, India). Triple distilled water was used in this study. A stock solution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results